Jii Bum Lee

NVL-655 Is a Selective and Brain-Penetrant Inhibitor of Diverse ALK-Mutant Oncoproteins, Including Lorlatinib-Resistant Compound Mutations

Joshua C. Horan, Anupong Tangpeerachaikul, Aurélie Swalduz et al. · Cancer Discovery · 2024 · 45 citations · Full text

Medicine, Oncology, Pharmacology +13

Comprehensive immune profiling and immune-monitoring using body fluid of patients with metastatic gastric cancer

Hyung Soon Park, Woo Sun Kwon, Sejung Park et al. · Journal for ImmunoTherapy of Cancer · 2019 · 38 citations · Full text

Life Sciences, Immunology, Oncology +17

Association between Fusobacterium nucleatum and patient prognosis in metastatic colon cancer

Jii Bum Lee, Kyunga Kim, Ho Yeon Cho et al. · Scientific Reports · 2021 · 38 citations · Full text

Medicine, Oncology, Pathology +14

Overexpression of PVR and PD-L1 and its association with prognosis in surgically resected squamous cell lung carcinoma

Jii Bum Lee, Min Hee Hong, Sung Yong Park et al. · Scientific Reports · 2021 · 28 citations · Full text

Medicine, Cancer Biology, Oncology +17

Phase 2 study of TAS-117, an allosteric akt inhibitor in advanced solid tumors harboring phosphatidylinositol 3-kinase/v-akt murine thymoma viral oncogene homolog gene mutations

Jii Bum Lee, Minkyu Jung, Seung‐Hoon Beom et al. · Investigational New Drugs · 2021 · 26 citations · Full text

Medicine, Oncology, Pharmacology +15